Description
ELISA for the Quantitative determination of neutralizing antibody to the SARS-CoV-2 Spike RBD trimer of the Omicron variant in serum and plasma samples. With Omicron designated by the WHO as the newest Variant of Concern, the transimissibility of the coronavirus has created alarm around the world. Accurate, sensitive and specific quantification of neutralizing antibodies to COVID-19 Omicron variant is imperative in the tweaking and development of vaccines, therapies and preventative drugs. As other Krishgen ELISA, these kits are based on monoclonal antibody detection for better sensitivity. Proprietary stabilizers and blockers for optimal signal:noise ratio, with specific antibodies allow for a robust ELISA. Features include a standard, ready-to-use protocol, and the option to run serum or plasma samples